Pyzchiva Co-Pay Program (Sandoz One Source)
Sandoz Inc. · Pyzchiva
Patient pays: eligible commercially insured patients may pay as little as $0 per treatment
commercial insurance
We couldn’t confirm the current terms - call the program to verify.
Patient assistance
Tell us your insurance and household details. We’ll show you every Pyzchiva assistance program you may qualify for - the real manufacturer and foundation programs, not a discount card - with sources and a direct link to apply. About a minute, no login.
Every Pyzchiva program linked to its official source, with the date we checked it - rules, income limits, and application links included.
Pyzchiva (ustekinumab-ttwe) is an il-12/il-23 inhibitor (biologic, ustekinumab biosimilar) made by Samsung Bioepis (developer); Sandoz (U.S. commercializer). It is commonly prescribed for: Plaque psoriasis, Psoriatic arthritis, Crohn's disease, Ulcerative colitis.
Tell us five things. We’ll do the rest.
Reference
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Sandoz Inc. · Pyzchiva
Patient pays: eligible commercially insured patients may pay as little as $0 per treatment
commercial insurance
We couldn’t confirm the current terms - call the program to verify.
Common questions
Related drugs